SHARESIFT
Healthcare · data ~15-min delayed
262.82 USD +1.11%
| Price | 262.82 USD |
| Day change | +1.11% |
| Market cap | 464.43B |
| 52-week range | 190.75 – 269.39 |
| P/E (trailing) | 73.6 |
| Dividend yield | 2.63% |
| Payout ratio | 190.40% |
| Beta | 0.28 |
| Sector | Healthcare |
| Value score | 26 / 100 |
How the value score is calculated: 13 published tests, weighted to 100.
AbbVie Inc. (ABBV) scores 26/100 on this site's value model, in the lower band: most of the valuation measures it checks sit on the richer side. It trades at 73.6 times trailing earnings and is classified in Healthcare. The dividend yield is 2.63%, paid from 190% of earnings. On its filings it passes 6 of the nine Piotroski checks, a mixed picture. Its Altman Z-Score places it in the grey zone. These are automated readings of reported figures, not a recommendation.
Piotroski F-Score 6 / 9 — nine pass/fail checks on profitability, leverage and efficiency, comparing the latest financial year with the one before.
Altman Z-Score 2.63 — Grey zone.
Updated · prices ~15-min delayed, fundamentals as last reported
Open full interactive analysis →See how it ranks: US stocks by value score
Value scoring · Piotroski F-Score · Altman Z · technicals · dividends — free, no sign-up.